These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36243829)

  • 1. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
    King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
    Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
    Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
    J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement.
    Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    Sevco TJ; Masch WR; Maturen KE; Mendiratta-Lala M; Wasnik AP; Millet JD
    AJR Am J Roentgenol; 2021 Sep; 217(3):644-650. PubMed ID: 34259543
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.
    Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG
    AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
    Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
    Li W; Li L; Zhuang BW; Ruan SM; Hu HT; Huang Y; Lin MX; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
    Eur Radiol; 2021 Sep; 31(9):6758-6767. PubMed ID: 33675388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
    Tiyarattanachai T; Fetzer DT; Kamaya A
    AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
    Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
    Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
    Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Training in LI-RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter-reader Agreement in MRI Interpretation?
    Zhang N; Xu H; Ren AH; Zhang Q; Yang DW; Ba T; Wang ZC; Yang ZH
    J Magn Reson Imaging; 2021 Dec; 54(6):1922-1934. PubMed ID: 33963801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive predictive value of LI-RADS US-3 observations: multivariable analysis of clinical and imaging features.
    Tse JR; Shen L; Tiyarattanachai T; Bird KN; Liang T; Yoon L; Kamaya A
    Abdom Radiol (NY); 2023 Jan; 48(1):271-281. PubMed ID: 36253490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
    Lee S; Kim SS; Chang DR; Kim H; Kim MJ
    Clin Mol Hepatol; 2020 Jul; 26(3):340-351. PubMed ID: 32492765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.